Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, February 20, 2025

Unlocking Cellular Youth: The Protein That Reverses Aging

 How long before your competent? doctor gets further research on this done to solve your accelerated aging from your stroke? NEVER, because incompetence?

Do you prefer your doctor incompetence NOT KNOWING? OR NOT DOING?

Your competent? doctor started working on Integrin β1 years ago, right?

Integrin β1 and the Repair after Nervous System Injury October 2022

The latest here:

Unlocking Cellular Youth: The Protein That Reverses Aging

Summary: Scientists have identified a key protein, AP2A1, that may hold the secret to reversing cellular aging. The study found that suppressing AP2A1 in older cells led to rejuvenation, while overexpressing it in young cells accelerated senescence. This protein interacts with integrin β1, which strengthens cell adhesion and contributes to the enlarged structure of aging cells.

By manipulating AP2A1, researchers could potentially develop new treatments to combat age-related diseases and improve skin health. The findings provide new insights into how stress fibers influence cell size and senescence. AP2A1 could serve as a biomarker for aging and a target for therapies aimed at slowing down or even reversing the aging process.

Key Facts:

  • Aging Protein Identified: AP2A1 plays a crucial role in maintaining the enlarged structure of aging cells.
  • Reversing Senescence: Suppressing AP2A1 rejuvenates older cells, while increasing it accelerates aging.
  • Potential Therapy Target: AP2A1 could be used to develop treatments for age-related diseases.

Source: Osaka University

There are a multitude of products for sale that promise the appearance of eternal youth by erasing wrinkles or firming up jaw lines; but what if we could truly turn back time, at the cellular level? Now, researchers from Japan have found a protein that may do just that.

In a study published this month in Cellular Signaling, researchers from Osaka University have revealed that a key protein is responsible for toggling between ‘young’ and ‘old’ cell states.

This shows a cell.
AP2A1 is a protein that is upregulated in the stress fibers of senescent cells, including fibroblasts, which create and maintain the skin’s structural and mechanical characteristics, and epithelial cells. Credit: Neuroscience News

As we age, older, fewer active cells, known as senescent cells, accumulate in multiple organs. These cells are noticeably larger than younger cells, and exhibit altered organization of stress fibers, the structural parts of cells that help them move and interact with their environment.

“We still don’t understand how these senescent cells can maintain their huge size,” says lead author of the study Pirawan Chantachotikul.

“One intriguing clue is that stress fibers are much thicker in senescent cells than in young cells, suggesting that proteins within these fibers help support their size.”

To explore this possibility, the researchers examined AP2A1 (Adaptor Protein Complex 2, Alpha 1 Subunit). AP2A1 is a protein that is upregulated in the stress fibers of senescent cells, including fibroblasts, which create and maintain the skin’s structural and mechanical characteristics, and epithelial cells.

The researchers eliminated AP2A1 expression in older cells and overexpressed AP2A1 in young cells to determine the effect on senescence-like behaviors.

“The results were very intriguing,” explains Shinji Deguchi, senior author. “Suppressing AP2A1 in older cells reversed senescence and promoted cellular rejuvenation, while AP2A1 overexpression in young cells advanced senescence.”

Furthermore, the researchers found that AP2A1 is often closely associated with integrin β1, a protein that helps cells latch onto the scaffolding-like collagen matrix that surrounds them, and that both AP2A1 and integrin β1 move along stress fibers within cells.

In addition, integrin β1 strengthened cell–substrate adhesions in fibroblasts; this might explain the cause of the raised or thickened structures characteristic of senescent cells.

“Our findings suggest that senescent cells maintain their large size through improved adhesion to the extracellular matrix via AP2A1 and integrin β1 movement along enlarged stress fibers,” concludes Chantachotikul.

Given that AP2A1 expression is so closely linked to signs of aging in senescent cells, it could potentially be used as a marker for cellular aging. The research team’s work may also provide a new treatment target for diseases that are associated with old age.

About this genetics and aging research news

Author: Saori Obayashi
Source: Osaka University
Contact: Saori Obayashi – Osaka University
Image: The image is credited to Neuroscience News

Original Research: Open access.
AP2A1 modulates cell states between senescence and rejuvenation” by Pirawan Chantachotikul et al. Cellular Signaling

No comments:

Post a Comment